Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tiandan Tongluo
- Development stage
- Phase 4
- Lead developer
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Tiandan Tongluo is a Traditional Chinese Medicine (TCM) formulation, typically administered as a capsule, developed for the treatment of cerebral infarction (ischemic stroke) during the recovery period. It is specifically indicated for patients exhibiting TCM patterns of meridian obstruction, wind-phlegm, and blood stasis. The formulation aims to improve neurological function and promote recovery by addressing these underlying pathological patterns. It is currently being evaluated in clinical trials sponsored by the Guangdong Provincial Hospital of Traditional Chinese Medicine to assess its efficacy and safety in post-stroke rehabilitation.
- Brand names
- Tiandan Tongluo Capsule
- Other names
- Tiandan Tongluo CapsuleTiandan Tongluo Jiaonang
Beyond the preview
Go deeper on Tiandan Tongluo.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tiandan Tongluo.